| Serial Number | 97638096 |
| Word Mark | HERBION NATURALS |
| Filing Date | Wednesday, October 19, 2022 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Monday, June 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 19, 2023 |
| Description of Mark | The mark consists of the word "HERBION" in black text having two green leaves with white veins on top of the letter "I," over the word "NATURALS" in black text. |
| Goods and Services | Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inducing erections; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in discouraging the smoking habit; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Alginates for pharmaceutical purposes; Almond milk for pharmaceutical purposes; Aloe vera preparations for pharmaceutical purposes; Aluminium acetate for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bicarbonate of soda for pharmaceutical purposes; Bismuth preparations for pharmaceutical purposes; Bismuth subnitrate for pharmaceutical purposes; Bromine for pharmaceutical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Caustics for pharmaceutical purposes; Creosote for pharmaceutical purposes; Cytostatics for pharmaceutical purposes; Dermatological pharmaceutical products; Dextrins for pharmaceutical use; Digestives for pharmaceutical purposes; Effervescent analgesic pharmaceutical preparations; Ethers for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Extracts of hops for pharmaceutical purposes; Ferments for pharmaceutical purposes; Fish meal for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Flaxseed meal for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes; Gardenia for pharmaceutical purposes; Guaiacol for pharmaceutical purposes; Hyaluronic acid for pharmaceutical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Iodine for pharmaceutical purposes; Linseed meal for pharmaceutical purposes; Liquorice for pharmaceutical purposes; Malt for pharmaceutical purposes; Meal for pharmaceutical purposes; Menthol for pharmaceutical purposes; Milk ferments for pharmaceutical purposes; Mint for pharmaceutical purposes; Ocular pharmaceuticals; Pepsins for pharmaceutical purposes; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis for pharmaceutical purposes; Royal jelly for pharmaceutical purposes; Starch for pharmaceutical purposes; Stick liquorice for pharmaceutical purposes; Sunburn preparations for pharmaceutical purposes; Turpentine for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat; Yeast extracts for medical, veterinary or pharmaceutical purposes; Yeast for pharmaceutical consumption; Yeast for pharmaceutical purposes; Yeast for medical, veterinary or pharmaceutical purposes; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes |
| Indication of Colors claimed | The color(s) green, white and black are claimed as a feature of the mark. |
| NOT AVAILABLE | "NATURALS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, January 1, 2009 |
| First Use In Commerce Date | Thursday, January 1, 2009 |
| Party Name | Herbion USA Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Fort Mill, SC 29708 |
| Party Name | Herbion USA Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Fort Mill, SC 29708 |
| Event Date | Event Description |
| Friday, October 28, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, October 22, 2022 | NEW APPLICATION ENTERED |
| Friday, October 28, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 28, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, November 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 3, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, August 2, 2023 | ASSIGNED TO EXAMINER |
| Friday, August 11, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 11, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 11, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 11, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 11, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 30, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 10, 2023 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Wednesday, March 6, 2024 | OPPOSITION DISMISSED NO. 999999 |
| Wednesday, March 6, 2024 | TTAB RELEASE CASE TO TRADEMARKS |
| Wednesday, March 6, 2024 | OPPOSITION TERMINATED NO. 999999 |
| Tuesday, April 16, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, May 2, 2024 | USE AMENDMENT FILED |
| Thursday, May 2, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Monday, June 3, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, June 4, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 10, 2023 | OPPOSITION INSTITUTED NO. 999999 |